# Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

> **NCT06483659** · PHASE2 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 152 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06483659
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06483659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06483659, "Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06483659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*